A pilot study on the impact of congenital thrombophilia in COVID-19.

Authors :: de la Morena-Barrio ME
Bravo-Pérez C
de la Morena-Barrio B
Orlando C
Cifuentes R
Padilla J
Miñano A
Herrero S
Marcellini S
Revilla N
Bernal E
Gómez-Verdú JM
Jochmans K
Herranz MT
Vicente V
Corral J
Lozano ML
Source :: European journal of clinical investigation [Eur J Clin Invest] 2021 May; Vol. 51 (5), pp. e13546. Date of Electronic Publication: 2021 Mar 25.
Publication Year :: 2021

Subjects :: Adult
Aged
Antithrombin III genetics
Antithrombin III Deficiency blood
Antithrombin III Deficiency complications
Antithrombin III Deficiency genetics
COVID-19 complications
COVID-19 physiopathology
Cohort Studies
Factor V Deficiency blood
Factor V Deficiency complications
Factor V Deficiency genetics
Female
Fibrin Fibrinogen Degradation Products
Humans
Hypoprothrombinemias blood
Hypoprothrombinemias complications
Hypoprothrombinemias genetics
Intensive Care Units statistics & numerical data
Logistic Models
Male
Middle Aged
Mortality
Pilot Projects
Protein C genetics
Protein C Deficiency blood
Protein C Deficiency complications
Protein C Deficiency genetics
Protein S genetics
Protein S Deficiency blood
Protein S Deficiency complications
Protein S Deficiency genetics
Respiratory Distress Syndrome blood
Respiratory Distress Syndrome physiopathology
SARS-CoV-2
Severity of Illness Index
Thrombophilia complications
Thrombophilia genetics
Thrombophilia physiopathology
Thrombosis physiopathology
COVID-19 blood
Thrombophilia blood
Thrombosis blood

Full Text Access

Tools